Video Experimental Relacionado
Updated: Jun 25, 2026
07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Peligros, trampas y posibilidades al hablar de riesgos médicos
S T Bogardus1, E Holmboe, J F Jekel
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06504, USA. bogardus@gwpo.ynhh.com
JAMA
|March 23, 1999
Resumen
Los médicos deben comunicar efectivamente los riesgos médicos a los pacientes, respetando la autonomía y el consentimiento informado. El uso de diversos formatos como ayudas cualitativas, cuantitativas y gráficas puede mejorar la comprensión del paciente de los riesgos y beneficios del tratamiento.
Área de la Ciencia:
- Ética médica y ética médica.
- Comunicación de Salud en la Comunicación de Salud
- Educación del Paciente Educación del Paciente
Sus antecedentes:
- Los médicos tienen el deber de discutir los riesgos médicos con los pacientes, manteniendo la autonomía y el consentimiento informado.
- Comunicar el riesgo médico es un desafío debido a las brechas de conocimiento, la incertidumbre de la cantidad de información y las dificultades de comprensión del paciente.
- La comunicación efectiva de riesgos requiere discutir tanto los riesgos de la intervención como los riesgos de la no intervención.
Objetivo del estudio:
- Para describir las características de la información de riesgo médico.
- Para esbozar los principales desafíos en la comunicación de información de riesgo a los pacientes.
- Sugerir métodos para presentar la información de riesgo en un formato comprensible.
Principales métodos:
- Revisión de la literatura sobre la comunicación de riesgos en la medicina.
- Análisis de los retos en la transmisión de información médica compleja.
- Síntesis de estrategias para mejorar la comprensión de los riesgos de los pacientes.
Principales resultados:
- La información de riesgo tiene características inherentes que complican la comunicación.
- Los desafíos clave incluyen las brechas de conocimiento de los médicos y la variabilidad de la comprensión del paciente.
- Se recomienda una combinación de formatos cualitativos, cuantitativos y gráficos.
Conclusiones:
- La comunicación clara de los riesgos médicos es esencial para la toma de decisiones informadas del paciente.
- Adaptar los formatos de comunicación a las necesidades individuales del paciente mejora la comprensión.
- La mejora de la comunicación de riesgos apoya el papel del médico como asesor de confianza.
Videos de Conceptos Relacionados
01:26Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:26Torts III
Types of Quasi-intentional Torts in Healthcare
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:11Hazard Rate
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...